HINDENBURG RESEARCH - Key Persons
Job Titles:
- Natera VP of Sales
- Vice - President at Waltham
- VP of Sales at Natera
Kamath was Natera's vice-president of commercial sales from October 2017 until May 2019, according to his LinkedIn profile.
Kamath is currently vice-president at Waltham, Massachusetts-based PerkinElmer, a medical diagnostic and testing company. In May 2020, Reuters reported that the Department of Justice was investigating PerkinElmer's alleged role in a "massive Medicare fraud" relating to billing for unnecessary cancer tests. Previously he worked at BioReference Labs, which was alleged to have had extensive mob ties.
Marcy Miranda is listed on MGML's IRS Form 1023 as the organization's Secretary. Miranda, a Dallas-based public relations executive, said she agreed to serve as a trustee, "as a favor to someone I know who put it together." She added, "that was years ago, and I had honestly forgotten about [MGML.]"
When asked if Deepti Gupta was the person who asked her to join its board, Miranda paused a moment before answering, "yes."
"[MGML] was explained to me as something that would only require my signature. And because it was a charity, I felt was no reputational risk," said Miranda.
Job Titles:
- CEO
- Natera CEO
- Natera in 2010 As VP of Sales
Chapman joined Natera in 2010 as VP of Sales and rose through the ranks to Chief Commercial Officer, Chief Operating Officer, and then CEO starting in January 2019. Revenues attributable to Natera's U.S. sales force accounted for 89% of sales in 2021, up from 80% in 2019. [Pg. 76]
Natera CEO Chapman: "The prior authorization process can delay access to treatments…This administrative hurdle has been identified as a major issue in the healthcare industry that impacts patient access to care."
Natera CEO Chapman: "The report makes an allegation that one of our former employees who left in 2019 had a personal relationship with a senior member of MGML. To my knowledge, we do not know whether or not that is true."
Natera CEO Chapman: "MGML performed prior authorization services on roughly 11% of our volume in 2021 and we estimate less than 7% of our volumes going forward in 2022…We estimate that we make up approximately 25% of MGML's historical volume"
Natera CEO Chapman: "The report also went on to say that gender testing is Natera's main selling point." The claim is "wildly inaccurate".
Natera CEO Chapman: "We work with many prior auth providers. This is commonplace in the industry. They're one of the groups that we work with."
Natera CEO Chapman: "If the patient is determined to have a co-payment or deductible, we will bill the patient for their out-of-pocket responsibility"
Natera CEO Chapman: "Our requisition form was designed with expert physician input to accommodate demand for the addition of the single 22q microdeletion"
Chapman further attempted to discredit questions about MGML by citing the OIG guidance described in our report. In doing so, Chapman deeply mischaracterized our description of that opinion as a prohibition on labs offering prior authorization services.
Job Titles:
- Nikola Founder
- Nikola Founder and Executive Chairman
Nikola Founder and Executive Chairman Trevor Milton resigned from the company 10 days later.
Nikola founder Trevor Milton was subsequently criminally indicted in July 2021 on charges of securities and wire fraud. In October 2022, a jury found Milton guilty on 3 counts of fraud. The whistleblower's identity was protected until trial, during which he served as a key witness for the prosecution.